This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


LFB Group

Drug Names(s): Willfactin (EU), WILFACTIN, Willfact

Description: Wilfact is a very high purity plasma derived human von Willebrand factor (vWF) concentrate.

Deal Structure: LFB and Swedish Orphan Biovitrum
Sobi will, under the agreement with LFB BIOMEDICAMENTS, distribute Willfact in Germany, Sweden, Norway, Denmark, Estonia, Latvia, Lithuania, Slovenia, Czech Republic, Slovakia and Hungary.

Partners: Swedish Orphan Biovitrum

Wilfactin News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug